Research CombinationAnti-AgingFat LossEmerging EvidenceEducational · Not medical advice
MOTS-c + SS-31: Mitochondrial Optimization
A mitochondrial-targeted combination pairing two peptides with distinct but complementary mechanisms. MOTS-c enhances glucose metabolism and AMPK signaling while SS-31 (Elamipretide) stabilizes cardiolipin in the inner mitochondrial membrane, protecting against oxidative damage. Researched in contexts of aging, metabolic dysfunction, and exercise performance.
- 2
- Compounds
- Emerging
- Evidence Level
- 3
- Research Refs
- Anti-Aging
- Primary Goal
Mechanism
Compound 1Longevity
MOTS-c
Mitochondria-derived signaling peptide that activates AMPK and enhances glucose uptake. Multiple studies demonstrate improved exercise capacity and metabolic health in aged models.
+
+
Compound 2Longevity
SS-31
Targets cardiolipin in the inner mitochondrial membrane, reducing ROS production at the source. Phase 2/3 trials for mitochondrial myopathy and heart failure.
Synergistic Effect
Dual-pathway activation
MOTS-c × SS-31
Safety Notes
MOTS-c is a mitochondria-derived peptide studied primarily in preclinical models; human clinical data is very limited. SS-31 (elamipretide) is an investigational drug currently in Phase 2/3 clinical trials for Barth syndrome and heart failure — it is not approved for any indication. Neither compound is approved for general health or anti-aging use. Long-term safety profiles for both are still being established through ongoing clinical research.
Research References
Established
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
Cell Metab 2015PMID 25738459
Established
First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics
Br J Pharmacol 2014PMID 23991888
Established
Coordinated deficiency of complex I subunits in aging context
J Gerontol A Biol Sci Med Sci 2020PMID 31588495
GHK-Cu + Epithalon: Anti-Aging
Anti-AgingPreclinicalA longevity-focused stack pairing GHK-Cu's tissue rejuvenation and antioxidant gene activation with epithalon's proposed telomere-lengthening and pineal gland regulatory effects. GHK-Cu resets gene expression toward a younger phenotype by activating antioxidant and anti-inflammatory gene networks, while epithalon is proposed to slow cellular ageing by stimulating telomerase and regulating circadian and neuroendocrine function. The combination addresses anti-aging at both the cellular replication and tissue maintenance levels.
Thymalin + Epithalon: Immune-Longevity Protocol
Anti-AgingRecoveryPreclinicalBoth Thymalin and Epithalon are short bioregulatory peptides developed by Vladimir Khavinson and studied across decades of Russian gerontological research. Thymalin is associated with thymic peptide function and immune regulation in aging populations; Epithalon with pineal peptide activity, melatonin normalization, and telomere elongation. The combination is commonly referenced in longevity research for its dual immune-modulating and anti-aging mechanistic rationale.
AOD-9604 + Tirzepatide: Advanced Body Composition
Fat LossPreclinicalAOD-9604, a C-terminal fragment of human growth hormone associated with selective lipolytic activity, is paired with Tirzepatide's dual GIP and GLP-1 receptor agonism for appetite regulation and energy balance. The combination is explored for addressing fat reduction through complementary peripheral and central mechanisms.
⚠ Educational Use OnlyPeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.